Varenicline Improves Mood and Cognition during Smoking Abstinence

BACKGROUND: Neuronal nicotinic acetylcholine receptors (nAChRs) are a key target in medication development efforts for a range of neuropsychiatric disorders, including nicotine dependence. Varenicline, a partial agonist at the α4β2 nAChRs, is a new efficacious medication for nicotine dependence. Its...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Patterson, Freda, Jepson, Christopher, Strasser, Andrew A., Loughead, James, Perkins, Kenneth A., Gur, Ruben C., Frey, Joseph M., Siegel, Steven, Lerman, Caryn
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2615779/
https://ncbi.nlm.nih.gov/pubmed/18842256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2008.08.028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky